Management and 1-Year Outcome in Elderly Patients with Hip Fracture Surgery Receiving Anticoagulation (Warfarin or DOAc) or P2Y12 Antiplatelet Agents. [PDF]
Rostagno C +7 more
europepmc +1 more source
Newer agents in antiplatelet therapy: a review
Jennifer Yeung, Michael HolinstatCardeza Foundation for Hematologic Research, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USAAbstract: Antiplatelet therapy remains the mainstay in preventing aberrant platelet activation in ...
Yeung J, Holinstat M
doaj
Independent association of Lp(a) with platelet reactivity in subjects without statins or antiplatelet agents. [PDF]
Liu H, Fu D, Luo Y, Peng D.
europepmc +1 more source
Independent association of PCSK9 with platelet reactivity in subjects without statin or antiplatelet agents. [PDF]
Wang S, Fu D, Liu H, Peng D.
europepmc +1 more source
Meta-Analysis Addressing the Efficacy and Safety of Antiplatelet Agents in Patients With COVID-19. [PDF]
Patoulias D, Papadopoulos C, Doumas M.
europepmc +1 more source
Antiplatelet Agents Affecting GPCR Signaling Implicated in Tumor Metastasis. [PDF]
Rovati G +5 more
europepmc +1 more source
A cecal slurry mouse model of polymicrobial abdominal sepsis to evaluate the effects of antiplatelet agents. [PDF]
Mansour A +7 more
europepmc +1 more source
Tongue laceration in a patient taking antiplatelet agents during transcranial motor-evoked potential monitoring: a case report. [PDF]
Matsumoto K, Nakagawa H, Kitamura A.
europepmc +1 more source
Dextrans as anticoagulants and antiplatelet agents: protocol for a scoping review. [PDF]
Flinkier A +10 more
europepmc +1 more source

